August 26, 2020>> Congrats to the entire INX Limited team, who made history today by announcing the effectiveness of Security Token IPO

August 12, 2020>> Another important milestone for Zebra Medical Vision Ltd- innovative partnership for AI implementation with Canon USA

July 15, 2020>> Horn & Co. represented Pontifax’s Venture Lending Fund in a $30M Convertible Debt Financing Agreement with ProQR Therapeutics N.V

June 14, 2020>> Proud to be ranked, again, by IAM Magazine as one of top 4“highly recommended” Israeli firms in intellectual property transactions

May 13, 2020>> Vascular Biogenics Ltd. raises an additional $8.1 million, completing an aggregate $18.1 million raise. Yuval Horn, Keren Kanir and Shimrit Roznek represented VBL in this transaction.

May 4, 2020>> Horn & Co. has been recognized by Legal 500 as a “Tier 1” firm in Israel in the field of Healthcare and Life Sciences

March 30, 2020>> Proud of our client, Diagnostic Robotics Ltd. that developed a system for detecting COVID-19

February 20, 2020>> Yuval Horn noted once again as a Thought Leader Global Elite 2020 in Life Sciences by Who’s Who Legal, the only individual from Israel.

January 20, 2020>> “They were providing services to one of the more innovative projects coming out of Israel in blockchain and trying to secure SEC approval for a project, which is very difficult to get.”

December 18, 2019>> Paz Abercohen, Yuval Horn and Yonatan Levinstein of Horn & Co. represented Raziel Therapeutics in its $22 million series C round, led by Pontifax, with participation from existing investors as well as new investors, Catalyst Fund, Quark venture, Peregrine Investments and Wille AG.